- 我们的平台 What is G2H
- 科学原理 The Science of Polygenic Scoring
- 示例报告Sample Report
- 关于遗传检测 More about Genetic Testing
- 常见问题 FAQ
- 产品信息 Product Info
- 公司信息 Company Info
- 服务内容 All services
- 使用咨询 Consult before use
- 售后服务 Customer service
- 遗传咨询 Genetic counselling
- 临床咨询 Clinical counselling
- AI 虚拟咨询师 AI virtual counselling
- 近期活动 Recent activities
文章列表
- 关于我们
- 技术流程
- 产品外观
- 研发中
- Privacy Policy for use with order of Genetic Testing 隐私政策(适用于同时订购基因检测服务的用户)
- Privacy Policy for use with direct raw DNA data upload 隐私政策(适用于自行上传DNA数据文件的用户)
- Informed Consent for Raw Data Upload and Analysis 数据上传分析知情同意书
- Terms of Use 用户服务条款
- FAQ
- Videos
- Upload your DNA files 上传您的DNA文件
- Try G2H-CVD1.0
- Watch more about us at our YouTube channel
- G2H sample report view
- G2H-CVD1.0 心血管疾病风险评估示例报告 sample report Simplified Chinese
- G2H-CVD1.0 心血管疾病風險評估示例報告 sample report Traditional Chinese
- G2H-CVD1.0 sample report English
- G2H-CVD1.0 mobile
- 我们的服务范围和报价
- Gene to Health Limited Team Profile
- G2H Scope of Services and Quotation
- 基因智健有限公司简介
- 沈伯松教授简介
- G2H sample report
- Polygenic Risk Scores: Technology, Applications, and Potential in Predicting Health Traits and Disease Risk
- 什么是多基因风险评分
- PGS step by step: a brief pipeline
- How do we evaluate Polygenic Scoring?
- Which Polygenic Scoring method is better?
- The toolkit for modelling PGS
- The history of PGS: since 2009
- The Background of Polygenic Scoring
产品列表
产品分类
文章分类
- 我们的平台 What is G2H
- 科学原理 The Science of Polygenic Scoring
- 示例报告Sample Report
- 关于遗传检测 More about Genetic Testing
- 常见问题 FAQ
- 产品信息 Product Info
- 公司信息 Company Info
- 服务内容 All services
- 使用咨询 Consult before use
- 售后服务 Customer service
- 遗传咨询 Genetic counselling
- 临床咨询 Clinical counselling
- AI 虚拟咨询师 AI virtual counselling
- 近期活动 Recent activities
博客分类
论坛版块
- Healthcare
- 健康管理
- Agricultural
论坛主题列表
手册文章列表
Gene to Health Limited primarily focuses on developing multi-omics predictive models for common disease risks, conducting biomedical big data analysis and modeling, and providing bioinformatics research services. We are a pioneer in Asia focused on polygenic scoring technology, leveraging millions of disease-related genetic variants and other omics data to predict over 1000 traits and diseases. Our core product suite, G2H, provides personalized health management solutions in one platform, including risk assessments for chronic diseases, dietary optimization, lifestyle advisory, and cancer risk prediction. We aim to revolutionize disease prevention and improve early disease intervention by integrating advanced genomic analysis, ML and AI.
我们是来自香港大学医学院 (HKU Med) 的博士创业团队,拥有以Polygenic Scoring (多基因风险评分,PGS)的核心技术,基因智健(G2H)平台是我们开发的核心产品。该平台主要利用基于多组学大数据的统计机器学习模型分析用户数据,从而预测和评估上千种种人类疾病风险和健康表型,为您的健康人生保驾护航。
联系人: | Dr. CHEN Guolan Lane |
---|---|
电话: | +852 46404365 |
Email: | support@gene2h.com |
QQ: | 3028035047 |
微信: | lanechenhku |
微博: | u/7735987435 |
地址: | 1)Unit 707-34, 7F, Building 19W, No. 19 Science Park West Avenue, Hong Kong Science and Technology Park, Pak Shek Kok, N.T., Hong Kong 2)5 Sassoon Road, 1F, Pok Fu Lam, Hong Kong, China 3)Room 903, No. 91, Ke Feng Road, Huangpu District (Guangzhou Development Zone), Guangzhou, Guangdong Province, China 1)中国香港特别行政区新界白石角科技园西大道19号19W座7楼707-34单元 2)中国香港特别行政区薄扶林沙宣道5号1F 3)中国广东省广州市黄埔区(广州开发区)科丰路91号903 |
扫一扫企业微信客服,立即与我们沟通 (WeChat Customer Service)
Follow us at LinkedIn 关注领英